Sutro Biopharma, Inc.
STRO
$0.8578
$0.01021.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.86% | -4.87% | -48.49% | -1.60% | 17.51% |
| Total Depreciation and Amortization | 0.00% | 1.71% | 3.84% | 0.50% | 1.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.82% | 5.21% | 240.01% | -242.34% | -12.19% |
| Change in Net Operating Assets | -453.04% | 41.87% | -121.00% | -114.72% | 391.11% |
| Cash from Operations | 34.12% | 5.37% | -11.19% | -782.35% | 114.60% |
| Capital Expenditure | 92.67% | -9.93% | -28.99% | -9.52% | -69.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.67% | -117.03% | -40.21% | 286.03% | -223.34% |
| Cash from Investing | 115.87% | -118.58% | -40.60% | 283.25% | -225.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -98.87% | 9,289.79% |
| Repurchase of Common Stock | 66.67% | -650.00% | 67.57% | -100.00% | 90.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -190.91% | 375.00% | -102.36% | -98.95% | 2,913.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 49.80% | -634.62% | -81.23% | 227.69% | 729.03% |